本页面由Tiger Trade Technology Pte. Ltd.提供服务

Recursion Pharmaceuticals, Inc.

4.01
-0.3500-8.03%
盘后:4.00-0.0100-0.25%19:59 EDT
成交量:2,378.53万
成交额:9,669.24万
市值:21.45亿
市盈率:-3.92
高:4.37
开:4.31
低:3.91
收:4.36
52周最高:7.18
52周最低:2.77
股本:5.35亿
流通股本:5.22亿
量比:0.48
换手率:4.55%
股息:- -
股息率:- -
每股收益(TTM):-1.0219
每股收益(LYR):-1.4410
净资产收益率:-56.58%
总资产收益率:-27.33%
市净率:2.34
市盈率(LYR):-2.78

数据加载中...

2024/08/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/28

重要事件披露

Form 8-K - Current report
2024/08/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/08

重要事件披露

Form 8-K - Current report
2024/08/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/06

重要事件披露

Form 8-K - Current report
2024/07/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/07/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/07/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/07/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/07/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/07/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/07/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/07/08

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/06/27

关联方拟减持公告

Form144 | Recursion Pharmaceuticals高管Tina Marriott拟减持6000股,总价约43290美元